In today's daily health, the Food and Drug Administration has approved a new daily pill called Lipfenra that can lower cholesterol levels further than what can be achieved with statins. Those are the widely prescribed medications already on the market. Clinical trials show this new pill can bring levels of what's called bad cholesterol or LDL down to 50 or 60 or even lower.Doctors often recommend an LDL 70 and below for a healthy person. Joining us now is NBC News medical contributor Dr. . Natalie Azar.Good ...

How is Eli Lilly reinventing pharma? On this week’s “Money Talks” we interview David Ricks, the trillion-dollar drugmaker’s CEO https://t.co/WnWWivuUCK ...

Our podcast on markets, the economy and business. This week, an interview with David Ricks, CEO of Eli Lilly https://t.co/lCxqoAjt7A ...

The deal deepens Lilly’s longstanding presence in neuroscience drugs https://t.co/eOBCFN0YBq ...

Merck & Co. won regulatory approval for a pill version of powerful cholesterol medication that Wall Street analysts have said could generate billions of annual sales. https://t.co/yA1QYfuZeD ...

What exactly is Lilly buying with this thing, Madison. So Lilly is buying into this fast growing psychedelic space, which was once really on the fringes of drug development, but has gotten a lot more interesting and a lot more interest from drug makers over the last year or so. There are now a couple of companies that are nearing potentially FDA approval.They're in late stages of testing. AtaiBeckley is moving into late stages of testing. They have their lead drug is called BPL zero zero three.It's actually ...

Lily says that it is acquiring psychedelic drug developer Tai Beckley. And Lily will pay $675 in cash or $2.8% billion upfront and another1 billion if certain developmental and regulatory milestones are met. And so a Tai Beckley, their lead drug is related to the psychedelic drug DMT.And the company's testing it for treatment resistant depression. And it's a nasal spray that's a little bit like um J&J's drug spado. So it's administered in a clinic and then patients are monitored for a couple hours and again ...

Merck said the U.S. FDA has approved its cholesterol pill, the first of its kind to receive the health regulator’s ​nod, bolstering the drugmaker’s efforts to diversify beyond its blockbuster ‌cancer treatment Keytruda. https://t.co/N7MkOWpCfm https://t.co/CQwauU53AY ...

Eli Lilly has struck a deal to buy mental-health-focused AtaiBeckley for an initial $2.8 billion, continuing the drugmaker’s recent buying spree. https://t.co/C6X2UJZnOo ...